1
|
Wang WP: Pediatrics. 8th edition. People's
Medical Publishing House; Beijing: pp. 376–383. 2008, In
Chinese.
|
2
|
Pui CH: Recent research advances in
childhood acute lymphoblastic leukemia. J Formos Med Assoc.
109:777–787. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Gill Super HJ: A role for epigenetics in
the formation of chromosome translocations in acute leukemia.
Cancer Genet. 208:230–236. 2015. View Article : Google Scholar : PubMed/NCBI
|
4
|
Mourelatos Z, Dostie J, Paushkin S, Sharma
A, Charroux B, Abel L, Rappsilber J, Mann M and Dreyfuss G: miRNPs:
A novel class of ribonucleoproteins containing numerous microRNAs.
Genes Dev. 16:720–728. 2002. View Article : Google Scholar : PubMed/NCBI
|
5
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
Doench JG, Petersen CP and Sharp PA:
siRNAs can function as miRNAs. Genes Dev. 17:438–442. 2003.
View Article : Google Scholar : PubMed/NCBI
|
7
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Calin GA and Croce CM: MicroRNAs and
chromosomal abnormalities in cancer cells. Oncogene. 25:6202–6210.
2006. View Article : Google Scholar : PubMed/NCBI
|
9
|
Gong JN, Yu J, Lin HS, et al: The role,
mechanism and potentially therapeutic application of microRNA-29
family in acute myeloid leukemia. Cell Death Differ. 21:100–112.
2014. View Article : Google Scholar
|
10
|
Moarii M, Boeva V, Vert JP and Reyal F:
Changes in correlation between promoter methylation and gene
expression in cancer. BMC Genomics. 16:8732015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Zhang YY, Tian WP and Mei M: Interaction
between miR-21 and DNA methylation in different breast cancer
cells. Chin J Appl Physiol. 31:220–224. 2015.In Chinese.
|
12
|
Garzia L, Andolfo I, Cusanelli E, Marino
N, Petrosino G, De Martino D, Esposito V, Galeone A, Navas L,
Esposito S, et al: MicroRNA-199b-5p impairs cancer stem cells
through negative regulation of HES1 in medulloblastoma. PloS One.
4:e49982009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Lee KH, Lotterman C, Karikari C, Omura N,
Feldmann G, Habbe N, Goggins MG, Mendell JT and Maitra A:
Epigenetic silencing of MicroRNA miR-107 regulates cyclin-dependent
kinase 6 expression in pancreatic cancer. Pancreatology. 9:293–301.
2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Noonan EJ, Place RF, Pookot D, Basak S,
Whitson JM, Hirata H, Giardina C and Dahiya R: miR-449a targets
HDAC-1 and induces growth arrest in prostate cancer. Oncogene.
28:1714–1724. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Toyota M, Suzuki H, Sasaki Y, Maruyama R,
Imai K, Shinomura Y and Tokino T: Epigenetic silencing of
microRNA-34b/c and B-cell translocation gene 4 is associated with
CpG island methylation in colorectal cancer. Cancer Res.
68:4123–4132. 2008. View Article : Google Scholar : PubMed/NCBI
|
16
|
He X, He L and Hannon GJ: The guardian's
little helper: MicroRNAs in the p53 tumor suppressor network.
Cancer Res. 67:11099–11101. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Kalimutho M, Di Cecilia S, Del Vecchio
Blanco G, et al: Epigenetically silenced miR-34b/c as a novel
faecal-based screening marker for colorectal cancer. Br J Cancer.
104:1770–1778. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Lujambio A, Calin GA, Villanueva A, Ropero
S, Sánchez-Céspedes M, Blanco D, Montuenga LM, Rossi S, Nicoloso
MS, Faller WJ, et al: A microRNA DNA methylation signature for
human cancer metastasis. Proc Natl Acad Sci USA. 105:13556–13561.
2008. View Article : Google Scholar : PubMed/NCBI
|
19
|
Suzuki H, Yamamoto E, Nojima M, Kai M,
Yamano HO, Yoshikawa K, Kimura T, Kudo T, Harada E, Sugai T, et al:
Methylation-associated silencing of microRNA-34b/c in gastric
cancer and its involvement in an epigenetic field defect.
Carcinogenesis. 31:2066–2073. 2010. View Article : Google Scholar : PubMed/NCBI
|
20
|
Tsai KW, Wu CW, Hu LY, Li SC, Liao YL, Lai
CH, Kao HW, Fang WL, Huang KH, Chan WC and Lin WC: Epigenetic
regulation of miR-34b and miR-129 expression in gastric cancer. Int
J Cancer. 129:2600–2610. 2011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Liu C, Cheng H, Shi S, Cui X, Yang J, Chen
L, Cen P, Cai X, Lu Y, Wu C, et al: MicroRNA-34b inhibits
pancreatic cancer metastasis through repressing Smad3. Curr Mol
Med. 13:467–478. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Kruse JP and Gu W: Modes of p53
regulation. Cell. 137:609–622. 2009. View Article : Google Scholar : PubMed/NCBI
|
23
|
Teodoro JG, Parker AE, Zhu X and Green MR:
p53-mediated inhibition of angiogenesis through up-regulation of a
collagen prolyl hydroxylase. Science. 313:968–971. 2006. View Article : Google Scholar : PubMed/NCBI
|
24
|
Feng Z and Levine AJ: The regulation of
energy metabolism and the IGF-1/mTOR pathways by the p53 protein.
Trends Cell Biol. 20:427–434. 2010. View Article : Google Scholar : PubMed/NCBI
|
25
|
Raver-Shapira N, Marciano E, Meiri E,
Spector Y, Rosenfeld N, Moskovits N, Bentwich Z and Oren M:
Transcriptional activation of miR-34a contributes to p53-mediated
apoptosis. Mol Cell. 26:731–743. 2007. View Article : Google Scholar : PubMed/NCBI
|
26
|
Xiao R and Zhang R: Combined analysis on
morphology, immunology, cytogenetics and molecular biology (MICM)
classification of 55 patients with acute promyelocytic leukemia. J
Exp Hematol. 12:147–150. 2004.In Chinese.
|
27
|
Gao C, Zhao XX, Li WJ, Cui L, Zhao W, Liu
SG, Yue ZX, Jiao Y, Wu MY and Li ZG: Clinical features, early
treatment responses and outcomes of pediatric acute lymphoblastic
leukemia in China with or without specific fusion transcripts: A
single institutional study of 1,004 patients. Am J Hematol.
87:1022–1027. 2012. View Article : Google Scholar : PubMed/NCBI
|
28
|
Pigazzi M, Manara E, Baron E and Basso G:
MiR-34b targets cyclic AMP-responsive element binding protein in
acute myeloid leukemia. Cancer Res. 69:2471–2478. 2009. View Article : Google Scholar : PubMed/NCBI
|
29
|
Pigazzi M, Manara E, Bresolin S, Tregnago
C, Beghin A, Baron E, Giarin E, Cho EC, Masetti R, Rao DS, et al:
MicroRNA-34b promoter hypermethylation induces CREB overexpression
and contributes to myeloid transformation. Haematologica.
98:602–610. 2013. View Article : Google Scholar :
|
30
|
Munoz L, Nomdedéu JF, Villamor N, Guardia
R, Colomer D, Ribera JM, Torres JP, Berlanga JJ, Fernández C,
Llorente A, et al: Acute myeloid leukemia with MLL rearrangements:
Clinicobiological features, prognostic impact and value of flow
cytometry in the detection of residual leukemic cells. Leukemia.
17:76–82. 2003. View Article : Google Scholar : PubMed/NCBI
|
31
|
Cox MC, Panetta P, Venditti A, Del Poeta
G, Maurillo L, Tamburini A, Del Principe MI and Amadori S:
Fluorescence in situ hybridization and conventional cytogenetics
for the diagnosis of 11q23+/MLL+ translocation in leukaemia. Br J
Haematol. 121:953–955. 2003. View Article : Google Scholar : PubMed/NCBI
|
32
|
Inaba H and Pui CH: Glucocorticoid use in
acute lymphoblastic leukaemia. Lancet Oncol. 11:1096–1106. 2010.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Wang LQ and Chim CS: DNA methylation of
tumor-suppressor miRNA genes in chronic lymphocytic leukemia.
Epigenomics. 7:461–473. 2015. View Article : Google Scholar : PubMed/NCBI
|
34
|
Leucci E, Cocco M, Onnis A, De Falco G,
van Cleef P, Bellan C, van Rijk A, Nyagol J, Byakika B, Lazzi S, et
al: MYC translocation-negative classical Burkitt lymphoma cases: An
alternative pathogenetic mechanism involving miRNA deregulation. J
Pathol. 216:440–450. 2008. View Article : Google Scholar : PubMed/NCBI
|
35
|
Baylin SB, Herman JG, Graff JR, Vertino PM
and Issa JP: Alterations in DNA methylation: A fundamental aspect
of neoplasia. Adv Cancer Res. 72:141–196. 1998. View Article : Google Scholar
|
36
|
Cahill N and Rosenquist R: Uncovering the
DNA methylome in chronic lymphocytic leukemia. Epigenetics.
8:138–148. 2013. View Article : Google Scholar : PubMed/NCBI
|